Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML
Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML
Active, not recruiting · NCT03021330 · Registry updated 2025-05-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML | acute myeloid leukemia | Active, not recruiting | Phase 3 | 2025-05-30 | NCT03021330 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Hematology & Blood Diseases Hospital | Tianjin | China | 22 |